What Is AMH? Understanding Ovarian Reserve and Female Fertility
AMH is commonly used to assess ovarian reserve, but it is not the only measure of fertility potential. It should be interpreted together with age, ultrasound findings, medical history and clinical evaluation.
AMH stands for anti-Müllerian hormone. It is one of the commonly discussed markers in female fertility assessment, especially in ovarian reserve evaluation, egg freezing counseling and IVF planning. Many women first encounter AMH testing when they begin fertility evaluation.
AMH should not be understood as a single number that determines whether someone can become pregnant. It mainly reflects one aspect of ovarian reserve and may help physicians estimate ovarian response to stimulation. It should be interpreted together with age, menstrual history, ultrasound findings, hormone tests, medical history and overall health.
AMH is produced by granulosa cells in small ovarian follicles. In general, lower AMH may suggest reduced ovarian reserve or a lower expected response to stimulation, while higher AMH may be seen in people with a larger follicle pool or conditions such as polycystic ovary syndrome.
However, AMH is not a direct measure of egg quality. Egg quality is more closely related to age. A high AMH level does not guarantee good egg quality, and a low AMH level does not mean pregnancy is impossible. It should not be treated as a simple fertility score.
Age remains one of the most important fertility factors. As reproductive age increases, egg quantity and quality generally decline. AMH may also decline with age, but individual variation is significant. Some younger women may have low AMH, while some older women may still have moderate AMH values.
In IVF counseling, AMH can help guide stimulation planning. Patients with lower AMH may produce fewer eggs, while patients with higher AMH may require careful monitoring to reduce the risk of excessive response. AMH can help set expectations, but it cannot alone predict natural conception or IVF success.
AMH testing also has limitations. Results may vary across laboratories and testing methods. A single result should not be used in isolation, especially if it does not match age, ultrasound findings or clinical history. AMH cannot assess tubal patency, uterine receptivity, embryo chromosomal status or sperm quality.
Patients receiving AMH results should avoid panic or overconfidence. Low AMH should prompt professional consultation and individualized planning. High AMH should also be interpreted carefully, especially if there are signs of polycystic ovary syndrome.
For women not currently planning pregnancy, AMH may provide useful information, but decisions about egg freezing, fertility treatment or further testing should be made through medical consultation.
AMH is a valuable part of fertility assessment, but it is not a final judgment. This article is for educational purposes only and does not constitute medical advice.
This article is published by the WFA knowledge editorial team for informational purposes only and does not constitute medical advice. Please consult a licensed healthcare provider in your jurisdiction for clinical guidance.
